Borellini Flavia
SEC insider (Form 3/4/5 filer). CIK 0001867426. Director at PLIANT THERAPEUTICS, INC. (PLRX) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 9, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Borellini Flavia has filed insider reports for
- PLIANT THERAPEUTICS, INC. (PLRX): Director
- Revolution Medicines, Inc. (RVMD): Director
Borellini Flavia
CIK: 0001867426
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
